Vertex Pharmaceuticals

Yahoo Finance • 15 hours ago

Meet the Beaten-Down Biotech Stock Cathie Wood Loves That Wall Street Says May Soar 50%

Key Points Cathie Wood aims to identify innovators and invest in them early in their stories. Wood has been regularly adding to her position in this stock, and it’s one of her top holdings.10 stocks we like better than CRISPR Therapeutics... Full story

Yahoo Finance • 6 days ago

Validea Detailed Fundamental Analysis - VRTX

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INCORPORATED (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our Twin Momentum Investor model based on the published strategy of Dashan Huang. Thi... Full story

Yahoo Finance • 7 days ago

2 Healthcare Stocks For Beginner Investors With a 30-Year Time Horizon

Key Points Healthcare investments tend to be less cyclical than other stocks and help diversify your portfolio. Vertex has a profitable portfolio and promising pipeline, and its growth may be just getting started. DexCom's foothold within... Full story

Yahoo Finance • 13 days ago

Stifel Maintains Hold Rating on Vertex (VRTX), Keeps $445 Price Target

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best gene-editing stocks to buy according to hedge funds. On November 10, Stifel maintained a Hold rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). The firm also k... Full story

Yahoo Finance • 13 days ago

1 Incredible Reason to Buy Vertex Pharmaceuticals Stock in November

Key Points Vertex's core business continues to drive strong financial results. The biotech has an exciting late-stage pipeline that could make significant progress in the next few years. 10 stocks we like better than Vertex Pharmaceutical... Full story

Yahoo Finance • 15 days ago

VRTX Quantitative Stock Analysis

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INCORPORATED (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our Twin Momentum Investor model based on the published strategy of Dashan Huang. Thi... Full story

Yahoo Finance • 17 days ago

IWF, KO, VRTX, MCK: ETF Inflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Growth ETF (Symbol: IWF) where we have detected an approximate $408 inflow -- that's a 0... Full story

Yahoo Finance • 22 days ago

Vertex Unveils Positive 48-Week Data For Povetacicept In IgAN And PMN

(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) presented new interim data for its investigational therapy povetacicept (pove) in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) at the American Society of Nephrology (ASN) Ki... Full story

Yahoo Finance • 26 days ago

Vertex Pharma's Mixed Quarter: How Legacy Products Drove Its Beat

Vertex stock dipped Tuesday on a mixed third-quarter report, with the lion's share of its sales beat coming from its older CF drug. Continue Reading View Comments... Full story

Yahoo Finance • 27 days ago

Stocks making the biggest moves after hours: Palantir, Hims & Hers Health, Clorox and more

Check out the companies making headlines in after-hours trading. Palantir Technologies — Shares of Palantir rose 1% in extended trading after the software company reported quarterly results that beat Wall Street's estimates , with governme... Full story

Yahoo Finance • 27 days ago

Inflation-Proof Investing: Which Growth Stock Will Double Your Money in 6 Years?

Key Points Netflix and Vertex benefit from strong pricing power that could come in handy if inflation increases. Both companies are leaders in their niche with excellent growth prospects. They could deliver market-beating returns through... Full story

Yahoo Finance • 28 days ago

Vertex Pharmaceuticals (VRTX): Exploring Valuation After Promising Kidney Therapy Results and Growth in New Treatments

Vertex Pharmaceuticals (VRTX) is gaining attention as new clinical data for its kidney disease therapy, povetacicept, shows encouraging results. The company’s portfolio is also benefiting from steady cystic fibrosis sales and early momentu... Full story

Yahoo Finance • 28 days ago

My Top Growth Stock to Buy in November

Key Points Vertex Pharmaceuticals has three key ways to deliver strong growth. Two factors about the biotech company are especially comforting. While Vertex faces the risk of pipeline setbacks, its late-stage track record is pretty good.... Full story

Yahoo Finance • 28 days ago

Palantir, AMD, Pfizer, Robinhood, McDonald’s, and Many More Stocks to Watch This Week

Vertex, Corteva, and many more will also report earnings. On the economic front, The Supreme Court will hear arguments on the legality of Trump’s tariffs, and ADP will release October employment data. Continue Reading View Comments... Full story

Yahoo Finance • last month

H.C. Wainwright Reiterates a Buy Rating on Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the most profitable biotech stocks to buy. H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on October 21, setting... Full story

Yahoo Finance • last month

If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These

Key Points Novo Nordisk's business is well-equipped to rebound in the GLP-1 market. Vertex is set to launch a couple of new medicines in the next few years. Both stocks look attractively valued relative to their growth potential. 10 stock... Full story

Yahoo Finance • last month

Step Therapy Shifts and Pipeline Momentum Reshape the Membranous Nephropathy Treatment Landscape, according to Spherix Global Insights

EXTON, PA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The membranous nephropathy (MN) treatment paradigm is on the brink of transformation, with physicians signaling strong interest in novel mechanisms of action and shifting away from legacy regi... Full story

Yahoo Finance • last month

Vertex to Participate in the UBS Global Healthcare Conference on November 11

BOSTON, October 27, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in the UBS Global Healthcare Conference. Reshma Kewalramani, President and Chief Executive Officer will... Full story

Yahoo Finance • last month

Earnings To Watch: Vertiv (VRT) Reports Q3 Results Tomorrow

Data center products and services company Vertiv (NYSE:VRT) will be reporting results this Wednesday morning. Here’s what investors should know. Vertiv beat analysts’ revenue expectations by 12% last quarter, reporting revenues of $2.64 b... Full story

Yahoo Finance • last month

E-mini S&P and NQ Rally to End Week Strong as Tariff Tensions Ease

E-MINI S&P (DECEMBER) / E-MINI NQ (DECEMBER) S&P, yesterday’s close: Settled at 6702.50, up 33.75 on Friday and 107.25 on the week NQ, yesterday’s close: Settled at 24,986.50, up 155.25 on Friday and 589.50 on the week E-mini S&P and E-... Full story